Literature DB >> 8585760

Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation.

S L Spruance1, J D Kriesel, T G Evans, M B McKeough.   

Abstract

We studied susceptibility to herpes labialis by exposing 20 volunteers to experimental ultraviolet radiation (UVR) on three occasions at 3- to 4-month intervals. The number of patients who developed lesions after each session was 9/20 (45%), 9/20 (45%) and 14/20 (70%). Herpes simplex virus (HSV) was isolated from 21/29 (72%) of lesions sampled. Three patients never developed a lesion, 13 developed lesions on one or two of the three occasions, and 4 patients had a lesion following all three sessions. Seven of 33 (21%) lesions were 'immediate' lesions (developed within 48 h) and the others developed 3-7 days after UVR exposure (delayed lesions). Development of lesions correlated with historical susceptibility to sun-induced herpes labialis, but not with age, sex, years with herpes labialis, frequency of herpes labialis from all causes, or concurrent serum levels of cortisol, dehydroepiandrosterone, estradiol, progesterone or alpha 1-antitrypsin. Among normally menstruating females, a significant association was identified between the development of herpes labialis and the luteal phase of the menstrual cycle (8 cases of herpes labialis/11 attempts, RR = 14, P = 0.005). The lack of correlation between episodes of natural herpes labialis and susceptibility to experimental UVR-induced disease suggests that these events are controlled differently. The results of serial attempts to induce experimental herpes in each patient was most commonly inconsistent, indicating that individual patient susceptibility to UVR varies over time. While the explanation for this variation remains unclear, stages of the menstrual cycle may be important among women.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585760     DOI: 10.1016/0166-3542(95)00038-n

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  10 in total

Review 1.  Current management and recommendations for access to antiviral therapy of herpes labialis.

Authors:  Anthony Cunningham; Paul Griffiths; Peter Leone; Adrian Mindel; Rajul Patel; Lawrence Stanberry; Richard Whitley
Journal:  J Clin Virol       Date:  2011-09-01       Impact factor: 3.168

2.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

3.  C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene.

Authors:  John D Kriesel; Brandt B Jones; Nori Matsunami; Milan K Patel; Christine A St Pierre; Evelyn A Kurt-Jones; Robert W Finberg; Mark Leppert; Maurine R Hobbs
Journal:  J Infect Dis       Date:  2011-12-01       Impact factor: 5.226

Review 4.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

5.  Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.

Authors:  Nicholas J Moss; Amalia Magaret; Kerry J Laing; Angela Shaulov Kask; Minna Wang; Karen E Mark; Joshua T Schiffer; Anna Wald; David M Koelle
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

6.  Association between unprotected ultraviolet radiation exposure and recurrence of ocular herpes simplex virus.

Authors:  Christina Ludema; Stephen R Cole; Charles Poole; Jennifer S Smith; Victor J Schoenbach; Kirk R Wilhelmus
Journal:  Am J Epidemiol       Date:  2013-10-18       Impact factor: 4.897

7.  Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.

Authors:  T G Evans; D I Bernstein; G W Raborn; J Harmenberg; J Kowalski; S L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects.

Authors:  John D Kriesel; Amiteshwar Bhatia; Alun Thomas
Journal:  Hum Genome Var       Date:  2014-11-20

Review 9.  The Interplay between Adeno-Associated Virus and its Helper Viruses.

Authors:  Anita F Meier; Cornel Fraefel; Michael Seyffert
Journal:  Viruses       Date:  2020-06-19       Impact factor: 5.048

10.  Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis.

Authors:  Stephen W Mamber; Thomas Hatch; Craig S Miller; John V Murray; Cynthia Strout; John McMichael
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.